Ilika and Cirtec Medical Announce Miniature Stereax Solid State Battery Manufacturing and Commercialization Partnership
Ilika and Cirtec Medical announce today that they have deepened and broadened their relationship by entering into a memorandum of understanding, which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, MA. This will reinforce Cirtec’s ongoing activities in system level miniaturization for the medical device industry. Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialization activities.
“Our partnership with Cirtec reinforces a pathway towards commercialization of our Stereax battery technology,” commented Graeme Purdy, Ilika Chief Executive Officer, adding, “Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialization in the medical device industry to our partnership.”
Recommended AI: ITA Group Launches AI-Powered Channel Sales Claims Management Solution
“With over 20 years of experience in the design, development, and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets,” said Brian Highley, Cirtec Medical Chief Executive Officer.
Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist Internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs.
Recommended AI: The Transformational Impact of Low-code on the SaaS Industry in 2023
[To share your insights with us, please write to email@example.com]
Comments are closed.